‘India likely to grant indemnity to Moderna, soon’

New Delhi: India is close to agreeing to grant protection to Moderna against legal liability which will allow the immediate import of about 7 million doses of the US company’s Covid-19 vaccine, two people in the know told ET. These shots of the Moderna vaccine, donated by the US government, will reach India once the issue of indemnity is sorted out. This could happen as early as this week, they said.

“While India is agreeing to indemnity, we have asked them to suitably modify certain words in the agreement. Wordings make a difference; the analysing and understanding have to be country-specific. They need to be refined and that’s what has led to some delay,” a government official said. Moderna will be supplying its vaccine to India through Cipla. Last week, India’s drug regulator granted permission to Cipla to import the donated doses of Moderna’s mRNA vaccine.

“We are expecting a few million doses as a donation from the US government,” said the official. This will be minuscule, and India will have to depend on its own vaccine production, he added.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 85 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 115 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt